According to the COSMIC database, the frequency of AKT1 mutations is about 4% in breast cancer and 15% in meningiomas, and elevated expression is more common for endometrium (8.14%) and lung (8.73%) cancers (Table 2). Here, AKT1 is linked to cancer.